15 firms writing Biotech checks in New York, led by ACME Capital, Alumni Ventures, Amplify Partners — ranked by verified deal count with the companies behind.
Biotech in New York accounts for 11 tracked companies with verified cap-table data, 11 of which disclose round sizes totalling $1.3B. The median disclosed raise is $70M, and the largest is Kallyope at $487M, ahead of Ajax Therapeutics ($135M) and LB Pharmaceuticals ($130M).
The names that recur most often on these biotech cap tables are Lux Capital (3 companies), The Column Group (2 companies), Two Sigma Ventures (2 companies), Alexandria Venture Investments (2 companies), Mubadala Investment Company (1 company), Goldman Sachs Alternatives (1 company). By latest disclosed round, the market skews Series C (3), Series A (3), Series B (3), Grant (1).
All research · Investor directory · Company funding database · Fundraising library